Ironwood医药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Thomas A Mccourt | 8 | -498,165 |
Andrew Davis | 5 | -26,346 |
Ronald Silver | 4 | -16,544 |
Michael Shetzline | 3 | -68,264 |
Minardo John | 3 | -61,122 |
Sravan Kumar Emany | 3 | 40,178 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 17,604 | 280,916 | -263,312 |
最近6个月 | 17,604 | 294,129 | -276,525 |
最近12个月 | 53,676 | 403,559 | -349,883 |
最近18个月 | 53,676 | 729,221 | -675,545 |
最近36个月 | 53,676 | 902,381 | -848,705 |
Ironwood医药 内部交易
Ironwood医药 最新内部交易
Jon R Duane | 董事 | 2024-03-06 | 买入 | 6,920 | 121,028 |
$8.7
|
-7.01%
|
Sravan Kumar Emany | SVP, CFO | 2024-03-04 | 买入 | 10,684 | 301,733 |
$9.38
|
-13.75%
|
Thomas A Mccourt | CEO | 2024-02-12 | 卖出 | 177,164 | 832,774 |
$15.24
|
-46.92%
|
Andrew Davis | SVP, Chief Business Officer | 2024-02-12 | 卖出 | 9,846 | 273,636 |
$15.24
|
-46.92%
|
Ronald Silver | Principal Accounting Officer | 2024-02-12 | 卖出 | 7,908 | 161,477 |
$15.24
|
-46.92%
|
Michael Shetzline | CMO,SVP,Head-Res&Drug | 2024-02-12 | 卖出 | 38,618 | 394,911 |
$15.24
|
-46.92%
|
Minardo John | Chief Legal Officer | 2024-02-12 | 卖出 | 47,380 | 279,223 |
$15.24
|
-46.92%
|
Marla L Kessler | 董事 | 2023-12-14 | 卖出 | 9,926 | 96,572 |
$11.19
|
-27.70%
|
Andrew Davis | SVP, Chief Business Officer | 2023-11-20 | 卖出 | 3,287 | 217,374 |
$9.69
|
-16.51%
|
Sravan Kumar Emany | SVP, CFO | 2023-09-15 | 买入 | 36,072 | 188,730 |
$8.32
|
-2.76%
|